German pharma company acquires University of Basel start-up for 450 million Swiss francs
New technology uses living bacteria to fight cancer
28-Nov-2023 -
The biotech company T3 Pharmaceuticals, a spin-off from the University of Basel, is being acquired by the German pharmaceutical company Boehringer Ingelheim. T3 Pharma has developed a novel technology that uses live bacteria to deliver therapeutic proteins to cancer cells and the tumor ...
acquisitions
bacteria
cancer
+2